title: TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p.
authors.forename: M
authors.initials: M
authors.lastname: Jasek
authors.forename: L P
authors.initials: LP
authors.lastname: Gondek
authors.forename: N
authors.initials: N
authors.lastname: Bejanyan
authors.forename: R
authors.initials: R
authors.lastname: Tiu
authors.forename: J
authors.initials: J
authors.lastname: Huh
authors.forename: K S
authors.initials: KS
authors.lastname: Theil
authors.forename: C
authors.initials: C
authors.lastname: O'Keefe
authors.forename: M A
authors.initials: MA
authors.lastname: McDevitt
authors.forename: J P
authors.initials: JP
authors.lastname: Maciejewski
mesh_terms: D002872:Chromosome Deletion; D002886:Chromosomes, Human, Pair 17; D018628:Gene Dosage; D016158:Genes, p53; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics*; D019656:Loss of Heterozygosity; D009154:Mutation; D009190:Myelodysplastic Syndromes / Q000235:genetics*